Skip to main content
Premium Trial:

Request an Annual Quote

Genome Canada Funds Science Translation Training Project

NEW YORK (GenomeWeb News) – Genome Canada, Genome Quebec, and other partners have awarded C$1.1 million ($1.1 million) to researchers at Université Laval for a pilot project that will provide training for genomics researchers who seek to develop their discoveries into marketable applications.

The Boosting Entrepreneurial Skills and Training (BEST) in Genomics! project was selected for funding by Genome Canada under its Entrepreneurship Education in Genomics (EEG) Competition, which aims to support training for Canadian genomics researchers in how to maximize the value of their research and move their innovations into new products, technologies, systems, or processes.

Associate Professor Denis Garand of Laval's Department of Management will use the award to bring together 12 professors from Québec universities and industrial partners to provide education, training, and translational support activities for around 30 genomics and biotechnology research scientists.

Genome Canada provided 50 percent of the BEST in Genomics! project funding, with 25 percent coming from Génome Québec and another 25 percent from other sources, the university said.

"We want to help the researchers we select turn their ideas into innovations and commercial successes by giving them customized entrepreneurship training, right in their workplaces and at their own pace (four levels) through the digital teaching environment offered by Université Laval," Garand said in a statement.

"In three years, we will be ready to submit proposals to Genome Canada; this will eventually lead to the better commercialization of research results, patents, and discoveries," he added.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.